Insights from Vector Space
Insights, scenarios and models to help you understand how artificial intelligence
is transforming the way organisations work.
GenAI in Marketing and Communications
An analysis of 18 GenAI use cases for the communications function: which ones deliver real value, which remain hard to implement, and how to prioritize investments.
AI pharmacovigilance: the first proving ground for the EU AI Act in pharma
Oracle Argus at 19.4% of the market, ArisGlobal LifeSphere at 17.2%. NLP that codes MedDRA with AUC 0.97. The EMA Reflection Paper of September 2024 explicitly places PV within the regulated post-authorization scope. ICH E2D(R1) enters into force in the EU on March 18, 2026. Pharmacovigilance is the first pharma use case classified as high-risk.
AI Act, executive orders, Chinese laws: the world tries to rein in artificial intelligence
The US, Europe and China are building very different AI regulatory regimes. A guide to the regulatory updates every company needs to know in 2025.
AI Act and US state laws: how to build a compliance strategy that holds
The AI regulatory landscape is fragmented and rapidly evolving. EU AI Act, Colorado, Illinois, NYC, Utah: three common principles and a practical approach to avoid starting from scratch with every new law.
GenAI in the public sector: three lessons from the cases that work
Contact centers, transportation, citizen services: AI in the public sector is maturing. The cases that produce real results share three characteristics that most pilots ignore.
Personalized D2C nutraceuticals: the lesson of Care/of
Bayer acquired Care/of in 2020 for USD 225 million and shut it down in June 2024. AG1 generated USD 600 million in revenue in 2024 with a single SKU. Persona Nutrition returned to its founders and pivoted to B2B/HCP. Vitamins CAC EUR 45-80, LTV 300-600, first-month churn 20-30%. The pure quiz-subscription model is economically fragile.
Grok vs Mistral: two models, two philosophies, two different markets
xAI bets on speed of innovation and integration with X. Mistral bets on open source, digital sovereignty and efficiency. A head-to-head comparison for decision-makers.
HCP 360: the single view of the physician is still a promise in 2026
IQVIA OneKey tracks 25 million HCPs in 118 countries, Veeva OpenData covers 100+ countries, Salesforce Data Cloud opened connectors to Vault in 2025. Three platforms converge on the "single view" of the physician, but 30% of HCP records degrade every year and Sanita Trasparente is changing the rules of the Italian game from 2025.
GenAI in transportation: what worked, what disappointed
71% of transportation companies have already adopted or will adopt GenAI by 2026. But not all use cases have delivered on their promises. An updated map on where to invest and where to wait.
EU AI Act: the checklist for those who need to be ready
The EU AI Act is in force. Fines can reach up to 7% of global annual turnover. A practical guide for legal, compliance, risk and audit leaders on what to do and in what order.
Pet care vs livestock: two markets, two CRMs
Top 20 animal health: USD 38.6 billion in 2024. Zoetis global leader with over 11% market share, 65% companion / 35% livestock. Italy: 65 million pets, pet food EUR 3.1 billion (+13.4%), AISA Federchimica covering 95% of the Italian veterinary market. Reg. EU 2019/6: target -50% antimicrobials in farming by 2030. Two markets, two CRMs.
AI is changing how IT works: five moves that make the difference
Scaling AI in the enterprise does not just require new tools: it requires structural changes to the IT operating model. Five concrete practices adopted by CIOs who are already delivering results.
Mistral AI: the European model playing a different game
Mistral AI does not compete with OpenAI and Google on the same terms. It focuses on open source, computational efficiency, European digital sovereignty, and multilingualism. Here is where it works and where it shows its limits.
